Understanding glioma invasion: A necessity for effective therapy

World Neurosurgery

Volumn 80, Issue 3-4, 2013, Pages 281-283

  Peruzzi, Pierpaolo ^a   Chiocca, E Antonio ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glioma; Invasion; Matrix metalloproteinase 9; Migration; NF E2 related factor 2

Indexed keywords

BEVACIZUMAB; CADHERIN; CILENGITIDE; GADOLINIUM; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; INTEGRIN; MICRORNA; STAT3 PROTEIN; TEMOZOLOMIDE; VASCULOTROPIN;

CELL PROLIFERATION; GENETIC REASSORTMENT; GLIOBLASTOMA; GLIOMA CELL; IN VITRO STUDY; MATHEMATICAL MODEL; NUTRIENT AVAILABILITY; OVERALL SURVIVAL; PHENOTYPE; PROGRESSION FREE SURVIVAL; REVIEW; TUMOR INVASION;

EID: 84885190125     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.10.003     Document Type: Article

References (20)

1. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter The cytoskeleton B. Alberts, The Molecular Biology of the Cell 5th ed. 2008 Garland Science New York 965 1052
2. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter Cell junctions, cell adhesion, and the extracellular matrix B. Alberts, The Molecular Biology of the Cell 5th ed. 2008 Garland Science New York 1131 1178
3. D.K. Binder, M.S. Berger Proteases and the biology of glioma invasion J Neurooncol 56 2002 149 158
4. Q.S. Chu, B. Forouzesh, S. Syed, M. Mita, G. Schwartz, J. Cooper, J. Curtright, E.K. Rowinsky A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas Invest New Drugs 25 2007 359 367
5. C. Colin, B. Voutsinos-Porche, I. Nanni, F. Fina, P. Metellus, D. Intagliata, N. Baeza, C. Bouvier, C. Delfino, A. Loundou, O. Chinot, T. Lah, J. Kos, P.M. Martin, L. Ouafik, D. Figarella-Branger High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas Acta Neuropathol 118 2009 745 754
6. J.F. de Groot, G. Fuller, A.J. Kumar, Y. Piao, K. Eterovic, Y. Ji, C.A. Conrad Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice Neuro Oncol 12 2010 233 242
7. A. Giese, M.A. Loo, N. Tran, D. Haskett, S.W. Coons, M.E. Berens Dichotomy of astrocytoma migration and proliferation Int J Cancer 67 1996 275 282
8. J. Godlewski, M.O. Nowicki, A. Bronisz, G. Nuovo, J. Palatini, M. De Lay, J. Van Brocklyn, M.C. Ostrowski, E.A. Chiocca, S.E. Lawler MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells Mol Cell 37 2010 620 632
9. H. Hatzikirou, D. Basanta, M. Simon, K. Schaller, A. Deutsch 'Go or Grow': the key to the emergence of invasion in tumour progression? Math Med Biol 29 2012 49 65
10. O. Keunen, M. Johansson, A. Oudin, M. Sanzey, S.A. Rahim, F. Fack, F. Thorsen, T. Taxt, M. Bartos, R. Jirik, H. Miletic, J. Wang, D. Stieber, L. Stuhr, I. Moen, C.B. Rygh, R. Bjerkvig, S.P. Niclou Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma Proc Natl Acad Sci U S A 108 2011 3749 3754
11. V.A. Levin, S. Phuphanich, W.K. Yung, P.A. Forsyth, R.D. Maestro, J.R. Perry, G.N. Fuller, M. Baillet Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation J Neurooncol 78 2006 295 302
12. O. Méndez, J. Zavadil, M. Esencay, Y. Lukyanov, D. Santovasi, S.C. Wang, E.W. Newcomb, D. Zagzag Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres Mol Cancer 9 2010 133 142
13. S. Mertsch, N. Schmitz, A. Jeibmann, J.G. Geng, W. Paulus, V. Senner Slit2 involvement in glioma cell migration is mediated by Robo1 receptor J Neurooncol 87 2008 1 7
14. M.O. Nowicki, N. Dmitrieva, A.M. Stein, J.L. Cutter, J. Godlewski, Y. Saeki, M. Nita, M.E. Berens, L.M. Sander, H.B. Newton, E.A. Chiocca, S. Lawler Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3 Neuro Oncol 10 2008 690 699
15. C. Senft, M. Priester, M. Polacin, K. Schröder, V. Seifert, D. Kögel, J. Weissenberger Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells J Neurooncol 101 2011 393 403
16. R. Stupp, M.E. Hegi, B. Neyns, R. Goldbrunner, U. Schlegel, P.M. Clement, G.G. Grabenbauer, A.F. Ochsenbein, M. Simon, P.Y. Dietrich, T. Pietsch, C. Hicking, J.C. Tonn, A.C. Diserens, A. Pica, M. Hermisson, S. Krueger, M. Picard, M. Weller Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma J Clin Oncol 28 2010 2712 2718
17. M. Tamaki, W. McDonald, V.R. Amberger, E. Moore, R.F. Del Maestro Implantation of C6 astrocytoma spheroid into collagen type I gels: invasive, proliferative, and enzymatic characterizations J Neurosurg 87 1997 602 609
18. J.L. Wang, Y. Sun, S. Wu Gamma-irradiation induces matrix metalloproteinase II expression in a p53-dependent manner Mol Carcinog 27 2000 252 258
19. C. Wild-Bode, M. Weller, A. Rimner, J. Dichgans, W. Wick Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma Cancer Res 61 2011 2744 2750
20. S.P. Williams, M.O. Nowicki, F. Liu, R. Press, J. Godlewski, M. Abdel-Rasoul, B. Kaur, S.A. Fernandez, E.A. Chiocca, S.E. Lawler Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments Cancer Res 71 2011 5374 5380